Furthermore, when we quantified the levels of FGF2 in tbLCM, to our surprise, we did not observe any significant difference in the levels of soluble FGF2 in lung conditioned media from tumor bearing (tbLCM) mice as compared to tumor naïve mice. The gene discussed is FGF2; the disease is neoplasm.